Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(54)
•••
PWIB123
X
View Profile
View Bullboard History
Comment by
PWIB123
on Oct 09, 2024 9:55am
RE:Tomorrow
I'm very worried about the oncology prospects. These jokers always go silent when they are masking something, and they haven't said anything about TH-1902. I will be shocked if
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 09, 2024 9:23am
RE:Tomorrow
Everytine I hear the CEO they talk down cancer with comments like we are refocusing on commercial business and cancer trials are not linear... far away from the we have the key from not so long ago. &
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(56)
•••
Mannequin
X
View Profile
View Bullboard History
Post by
Mannequin
on Oct 09, 2024 9:06am
Tomorrow
Cancer is key to any upside at this point. I hope they see that tomorrow and have news.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 09, 2024 7:30am
New Press Release - Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV
MONTREAL, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on development and commercialization of innovative therapies, today announced three upcoming poster presentations at IDWeek 2024,...
read article.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 08, 2024 3:15pm
RE:RE:RE:RE:RE:Market Cap
Not much to be hopefull about a day before the business update. Even their Linkedin account looks abandoned. Probably chasing their tail trying to find new investors at 1$. I hope
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Oct 05, 2024 10:58am
RE:RE:RE:RE:Market Cap
If th1902 does'nt pan out and Egrifta supply and income becomes a serious issue in a near future well it will have been caused by imprudent management and board behavior. They will have been
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Oct 05, 2024 10:20am
Next week
Next week, Hoppe for the best and expect the worst. But like someone said, hope is not a strategy but that's what we're lest with thanks to those bozos.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Oct 01, 2024 3:00pm
Value creation
Hey it's almost Fall and value creation time if we rely on our CEO quote. Sort from Th1902 delivering on it's promises welter caught with less than 6 months of Egrifta inventory it seems
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Sep 30, 2024 8:55am
Wild guess
I would guess this week would be the time they throw something at us like a financing or some preliminary P1 data if good in case the Q3 call concludes on a sour note.
(14)
•••
LouisW
X
View Profile
View Bullboard History
Comment by
LouisW
on Sep 26, 2024 11:08pm
RE:$30/Share
I quit in March and earned some in UPST. I am glad i made this decision. I know itis not easy but you have to make decision to move on. Good luck.
(54)
•••
PWIB123
X
View Profile
View Bullboard History
Comment by
PWIB123
on Sep 26, 2024 8:06pm
RE:RE:Interest with Marathon
Since Marathon played both sides of the transaction, they need to bring their connections to the table and make something happen to benefit the ridiculous amount of warrants they required to negotiate
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 26, 2024 3:27pm
RE:RE:Interest with Marathon
How do you do that when you are faced with unpredictable revenues for god knows how long.
(43)
•••
SPCEO1
X
View Profile
View Bullboard History
Comment by
SPCEO1
on Sep 26, 2024 2:49pm
RE:Interest with Marathon
Lower SOFR rates will help but it is minimal at this point. They really need to refinance this debt but can only refinance the first $37 million now - $37 million because they likely have ade 3
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 26, 2024 7:30am
New Press Release - Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update
MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden